Latest filing published 26 May 2022 for 昭衍新药, €4.2M.
冯宇霞, listed as board member, appears in our data through filings on 昭衍新药 shares, published by SSE / SZSE (CSRC). In total, 4 filings cover trades dated from 20 May 2022 to 26 May 2022.
The open-market record consists of 4 sales worth €20.7M, with no purchase.
The record was last updated on 26 May 2022 with an open-market sale (€4.2M) in 昭衍新药. Publication is fast: at least half of the trades appear on SSE / SZSE (CSRC) on the same day. This delay matters because a trade only becomes useful information once it is public. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations